We are live on ! Find out more
SC

Steven Check Check Capital Management

AUM $7.52B
1-Year Est. Return 15.3%
 

Steven Check is the founder of Check Capital Management, a value-oriented firm known for research-driven equity portfolios and a long-term client focus. The firm often emphasizes understandable businesses purchased with a margin of safety. Check’s public commentary and portfolio disclosures appeal to investors who prefer classical value frameworks.

This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+15.3%
3 Year Est. Return
+66.62%
5 Year Est. Return
+84.34%
10 Year Est. Return
+232.1%
AUM
$1.01B
AUM Growth
+$40.2M
Cap. Flow
+$23.5M
Cap. Flow %
2.32%
Top 10 Hldgs %
77.19%
Holding
63
New
7
Increased
24
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$12.9M
2
MKL icon
Markel Group
MKL
+$12M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.56M
4
AFL icon
Aflac
AFL
+$2.25M
5
IBM icon
IBM
IBM
+$2.17M

Sector Composition

Rank Sector Weight
1 Financials 39.77%
2 Technology 18.8%
3 Healthcare 10.12%
4 Consumer Staples 5.32%
5 Consumer Discretionary 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
51
DELISTED
Monsanto Co
MON
$237K 0.02%
1,900
-600
-24% -$70.2K
F icon
52
Ford
F
$57.5B
$226K 0.02%
13,100
+800
+7% +$13K
EMC
53
DELISTED
EMC CORPORATION
EMC
$224K 0.02%
8,500
GE icon
54
GE Aerospace
GE
$361B
$222K 0.02%
1,760
-983
-36% -$125K
INTC icon
55
Intel
INTC
$476B
$211K 0.02%
+6,834
New +$187K
DUK icon
56
Duke Energy
DUK
$93.4B
$208K 0.02%
+2,799
New +$201K
PKX icon
57
POSCO
PKX
$17.3B
$205K 0.02%
+2,750
New +$201K
SMSI icon
58
Smith Micro Software
SMSI
$16.7M
$155K 0.02%
932
+81
+10% +$16.1K
TOVX icon
59
Theriva Biologics
TOVX
$10.8M
$17K ﹤0.01%
+1
New +$15.9K
BAC.PRL icon
60
Bank of America Series L
BAC.PRL
$3.95B
-182
Closed -$208K
C icon
61
Citigroup
C
$221B
-5,200
Closed -$248K
CF icon
62
CF Industries
CF
$19.6B
-4,000
Closed -$209K
SYNA icon
63
Synaptics
SYNA
$3.82B
-6,100
Closed -$366K

Similar funds

Steven Check's Q2 2014 Portfolio in Review

As of Q2 2014, Steven Check held 63 positions worth $1.01B, up 4.1% from $973M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Steven Check's Q2 2014 filing shows 7 new, 24 increased, 18 reduced and 4 closed positions. Its largest new stake was Markel Group: 19,017 shares worth $12.5M. The largest sale was Wells Fargo, an estimated $19M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 41% a quarter earlier, followed by Technology and Healthcare.

  • Steven Check's largest Q2 2014 buy was Markel Group: 19,017 shares worth $12.5M.
  • Steven Check added most to Verizon in Q2 2014, an estimated $12.9M increase.
  • Steven Check's biggest Q2 2014 reduction was Wells Fargo, cutting an estimated $19M.
  • Steven Check fully exited Synaptics in Q2 2014, selling an estimated $366K.
  • Steven Check's ten largest holdings make up 77% of its $1.01B portfolio in Q2 2014.
  • Steven Check opened 7 new positions and closed 4 in Q2 2014.
  • Steven Check's portfolio value rose 4.1% quarter-over-quarter to $1.01B.

Based on Check Capital Management's 13F filing for Q2 2014, filed 18 Jul 2014.